In addition, when looking at the tumor-draining lymph node, there were more TRP2-specific CD8+ T cells that were positive for the canonical central memory markers CD62L and CD44 in mice cured by the combination therapy versus the 10-μg CBD–IL-12 monotherapy (Fig. 3G). The gene discussed is SELL; the disease is neoplasm.